EVI1 and hematopoietic disorders: history and perspectives.
The ecotropic viral integration site 1 (EVI1) gene was identified almost 20 years ago as the integration site of an ecotropic retrovirus leading to murine myeloid leukemia. Since its identification, EVI1 has slowly been recognized as one of the most aggressive oncogenes associated with human leukemia. Despite the effort of many investigators, still very little is known about this gene. The mechanism by which EVI1 operates in the transformation of hematopoietic cells is not known, but it is clear that EVI1 upregulates cell proliferation, impairs cell differentiation, and induces cell transformation. In this review, we summarize the biochemical properties of EVI1 and the effects of EVI1 in biological models.
Nucifora
Giuseppina
G
Department of Pathology, University of Illinois at Chicago, 60607, United States. nucifora@uic.edu
Laricchia-Robbio
Leopoldo
L
Senyuk
Vitalyi
V
D000595:Amino Acid Sequence; D000818:Animals; D004268:DNA-Binding Proteins / Q000266:history / Q000502:physiology; D006402:Hematologic Diseases / Q000378:metabolism* / Q000473:pathology; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D000074008:MDS1 and EVI1 Complex Locus Protein; D051379:Mice; D008969:Molecular Sequence Data; D015514:Oncogene Proteins, Fusion; D010802:Phylogeny; D011519:Proto-Oncogenes / Q000502:physiology; D017386:Sequence Homology, Amino Acid; D014157:Transcription Factors / Q000266:history / Q000502:physiology
D004268:DNA-Binding Proteins; D000074008:MDS1 and EVI1 Complex Locus Protein; C063575:MECOM protein, human; C499305:Mecom protein, mouse; D015514:Oncogene Proteins, Fusion; D014157:Transcription Factors